Science Explorer Interactive view Map
Company · Cambridge · United Kingdom

Kymab (United Kingdom)

kymab.comROR OpenAlex
Research works
30
▲ 459% vs 2013–17
Citations
884
29.8 per fractional work
Top-10% rate
36.8%
record average 16.5%
Open access
55%
world 28%

Not ranked overall: Kymab (United Kingdom) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.16× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 4.55× its world share, 1 worksBiochemistry, Geneti…Immunology and Microbiology: 14.49× its world share, 1 worksImmunology and Micro…Computer Science: 0.66× its world share, 0 worksComputer ScienceEngineering: 0.34× its world share, 0 worksEngineeringEnvironmental Science: 0.27× its world share, 0 worksEnvironmental ScienceMedicine: 2.54× its world share, 2 worksMedicine1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 14.5×. Every wedge is a field page.

Which keywords describe research at Kymab (United Kingdom)?

By fractional works in all years, weighted toward what it does more of than the world: Glycosylation, Monoclonal Antibodies, Therapeutic Antibodies, Tumor Microenvironment, Immune Checkpoint Blockade, PD-1 and PD-L1, Antibody Engineering and Fc Receptors.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 20 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 20 words, with their numbers
  1. Glycosylation4▲ 63×3 topics
  2. Monoclonal Antibodies4▲ 92×2 topics
  3. Therapeutic Antibodies4▲ 102×2 topics
  4. Epidemiology3▲ 2.9×28 topics
  5. Tumor Microenvironment3▲ 32×3 topics
  6. Immune Checkpoint Blockade3▲ 198×1 topic
  7. PD-1 and PD-L13▲ 198×1 topic
  8. Antibody Engineering3▲ 107×1 topic
  9. Fc Receptors3▲ 107×1 topic
  10. Inflammation2▲ 3.2×10 topics
  11. Cancer2▲ 4.7×9 topics
  12. Immunity2▲ 18×5 topics
  13. Vaccine2▲ 13×8 topics
  14. Cancer Immunotherapy1▲ 32×2 topics
  15. Autoimmunity1▲ 19×2 topics
  16. Innate Immunity1▲ 11×7 topics
  17. Bioinformatics1▲ 32×2 topics
  18. Immunotherapy1▲ 5.8×3 topics
  19. Lymphoma1▲ 25×2 topics
  20. Genomics1▲ 10.0×3 topics

Which research topics does Kymab (United Kingdom) publish most on?

By volume in 2022–2025: Monoclonal and Polyclonal Antibodies Research, Biomedical Text Mining and Ontologies, Robotics and Automated Systems and Hand Gesture Recognition Systems.

Monoclonal and Polyclona…0Monoclonal and Polyclonal Antibodies Research: 0 fractional worksBiomedical Text Mining a…0Biomedical Text Mining and Ontologies: 0 fractional worksRobotics and Automated S…0Robotics and Automated Systems: 0 fractional worksHand Gesture Recognition…0Hand Gesture Recognition Systems: 0 fractional worksTransgenic Plants and Applications: 0 fractional worksBacterial Infections and Vaccines: 0 fractional worksAntibiotic Resistance in…0Antibiotic Resistance in Bacteria: 0 fractional worksDermatology and Skin Diseases: 0 fractional worksImmune Cell Function and Interaction: 0 fractional worksT-cell and B-cell Immuno…0T-cell and B-cell Immunology: 0 fractional works
Radiology, Nuclear Medicine and ImagingMolecular BiologyControl and Systems EngineeringHuman-Computer Interaction5 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 0 works
  2. 2 Biomedical Text Mining and Ontologies Molecular Biology 0 works
  3. 3 Robotics and Automated Systems Control and Systems Engineering 0 works
  4. 4 Hand Gesture Recognition Systems Human-Computer Interaction 0 works
  5. 5 Transgenic Plants and Applications Biotechnology 0 works
  6. 6 Bacterial Infections and Vaccines Microbiology 0 works
  7. 7 Antibiotic Resistance in Bacteria Molecular Medicine 0 works
  8. 8 Dermatology and Skin Diseases Dermatology 0 works
  9. 9 Immune Cell Function and Interaction Immunology 0 works
  10. 10 T-cell and B-cell Immunology Immunology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available55.4%not open44.6%

World: 28% of research is openly available.

with international co-authors50.0%domestic only50.0%

World: 19% is written across borders.

How has Kymab (United Kingdom)'s research output changed?

Output in 2018–2022 was 459% higher than in 2013–2017.

20002005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Cambridge

All research institutions in Cambridge

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.